Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2003-6-17
pubmed:abstractText
The aim of this pharmacogenomics study was to investigate the influence of different cytochrome P450 (CYP) genotypes in Helicobacter pylori eradication therapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Amoxicillin, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Ulcer Agents, http://linkedlifedata.com/resource/pubmed/chemical/Aryl Hydrocarbon Hydroxylases, http://linkedlifedata.com/resource/pubmed/chemical/CYP2C19 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/CYP3A protein, human, http://linkedlifedata.com/resource/pubmed/chemical/CYP3A4 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Clarithromycin, http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 CYP3A, http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 Enzyme System, http://linkedlifedata.com/resource/pubmed/chemical/DNA, http://linkedlifedata.com/resource/pubmed/chemical/Mixed Function Oxygenases, http://linkedlifedata.com/resource/pubmed/chemical/Omeprazole, http://linkedlifedata.com/resource/pubmed/chemical/Penicillins
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0002-9270
pubmed:author
pubmed:issnType
Print
pubmed:volume
98
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1010-5
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:12809821-Adult, pubmed-meshheading:12809821-Aged, pubmed-meshheading:12809821-Amoxicillin, pubmed-meshheading:12809821-Anti-Bacterial Agents, pubmed-meshheading:12809821-Anti-Ulcer Agents, pubmed-meshheading:12809821-Aryl Hydrocarbon Hydroxylases, pubmed-meshheading:12809821-Clarithromycin, pubmed-meshheading:12809821-Cytochrome P-450 CYP3A, pubmed-meshheading:12809821-Cytochrome P-450 Enzyme System, pubmed-meshheading:12809821-DNA, pubmed-meshheading:12809821-Drug Therapy, Combination, pubmed-meshheading:12809821-Female, pubmed-meshheading:12809821-Gastritis, pubmed-meshheading:12809821-Gastroscopy, pubmed-meshheading:12809821-Genotype, pubmed-meshheading:12809821-Helicobacter Infections, pubmed-meshheading:12809821-Helicobacter pylori, pubmed-meshheading:12809821-Humans, pubmed-meshheading:12809821-Male, pubmed-meshheading:12809821-Middle Aged, pubmed-meshheading:12809821-Mixed Function Oxygenases, pubmed-meshheading:12809821-Omeprazole, pubmed-meshheading:12809821-Penicillins, pubmed-meshheading:12809821-Peptic Ulcer, pubmed-meshheading:12809821-Pharmacogenetics, pubmed-meshheading:12809821-Polymerase Chain Reaction, pubmed-meshheading:12809821-Polymorphism, Restriction Fragment Length, pubmed-meshheading:12809821-Treatment Outcome
pubmed:year
2003
pubmed:articleTitle
The clinical role of cytochrome p450 genotypes in Helicobacter pylori management.
pubmed:affiliation
Department of Pharmacology, Pharmacogenomic Unit St. Orsola Hospital, University of Bologna, Bologna, Italy.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't